Epstein-Barr Virus DNA Levels Can Help Select Throat Cancer Patients for PET/CT Imaging

July 24, 2013

Chinese researchers have developed a more cost-effective way to use positron emission tomography and computed tomography (PET/CT) to detect metastases in patients with nasopharyngeal carcinoma.

The approach, which was published online July 15 in the Journal of Clinical Oncology, is based on Epstein-Barr virus (EBV) DNA levels and N stage.

"The resources of expensive PET/CT are scarce and there is insufficient PET/CT availability for all the nasopharyngeal carcinoma patients," said senior author Dr. Hai-Qiang Mai of Sun Yat-sen University Cancer Center in Guangzhou.